Characterization of the p53 mutants ability to inhibit p73β transactivation using a yeast-based functional assay

Oncogene

Volumn 22, Issue 34, 2003, Pages 5252-5260

  Monti, Paola ^a   Campomenosi, Paola ^b   Ciribilli, Yari ^a   Iannone, Raffaella ^a   Aprile, Anna ^a   Inga, Alberto ^a   Tada, Mitsuhiro ^c   Menichini, Paola ^a   Abbondandolo, Angelo ^a,d   Fronza, Gilberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c HOKKAIDO UNIVERSITY   (Japan)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Functional assay; P53 mutants; P73 ; Yeast

Indexed keywords

PROTEIN P53;

AMINO ACID SEQUENCE; ARTICLE; ASSAY; CODON; CONTROLLED STUDY; DNA BINDING; EUKARYOTE; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; MISSENSE MUTATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SPLICEOSOME; TRANSACTIVATION; TUMOR SUPPRESSOR GENE; YEAST;

BIOLOGICAL ASSAY; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; MUTATION; NUCLEAR PROTEINS; SACCHAROMYCES CEREVISIAE; TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EUKARYOTA;

EID: 0041353453     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206511     Document Type: Article

References (39)

1. Agami R, Blandino G, Oren M and Shaul Y. (1999). Nature, 399, 809-813.
2. Campomenosi P, Monti P, Aprile A, Abbondandolo A, Frebourg T, Gold B, Crook T, Inga A, Resnick MA, Iggo R and Fronza G. (2001). Oncogene, 20, 3573-3579
3. Cho Y, Gorina S, Jeffrey, PD and Pavletich, NP. (1994). Science, 265, 346-355.
4. Crook T, Marston NJ, Sara EA and Vousden KH. (1994). Cell, 79, 817-827.
5. Davison TS, Vagner C, Kaghad M, Ayed A, Caput D and Arrowsmith CH. (1999). J. Biol. Chem., 274, 18709-18714.
6. Di Como CJ, Gaiddon C and Prives C. (1999). Mol. Cell. Biol., 19, 1438-1449.
7. Flaman JM, Robert V, Lenglet S, Moreau V, Iggo R and Frebourg T. (1998). Oncogene, 16, 1369-1372.
8. Flores ER, Tsai KY, Crowley D, Sengupta S, Yang A, McKeon F and Jacks T. (2002) Nature, 416, 560-564.
9. Fontemaggi G, Kela I, Amariglio N, Rechavi G, Krishnamurti J, Strano S, Sacchi A, Givol D and Blandino G. (2002). J. Biol. Chem., 277, 43359-43368.
10. Gaiddon C, Lokshin M, Ahn J, Zhang T and Prives C. (2001). Mol. Cell. Biol., 21, 1874-1887.
11. Giaccia AJ and Kastan MB. (1998). Genes Dev., 12, 2973-2983.
12. Gong JG, Costanzo A, Yang HQ, Melino G, Kaelin Jr WG, Levrero M and Wang JY. (1999). Nature, 399, 806-809.
13. Inga A, Chen FX, Monti P, Aprile A, Campomenosi P, Menichini P, Ottaggio L, Viaggi S, Abbondandolo A, Gold B and Fronza G. (1999). Cancer Res., 59, 689-695.
14. Inga A, Cresta S, Monti P, Aprile A, Scott G, Abbondandolo A, Iggo R and Fronza G. (1997a). Carcinogenesis, 18, 2019-2021.
15. Inga A, Iannone R, Monti P, Molina F, Bolognesi M, Abbondandolo A, Iggo R and Fronza G. (1997b). Oncogene, 14, 1307-1313.
16. Inga A, Scott G, Monti P, Aprile A, Abbondandolo A, Burns PA and Fronza G. (1998). Carcinogenesis, 19, 741-746.
17. Jost CA, Marin MC and Kaelin Jr WG. (1997). Nature, 389, 191-194.
18. Kaelin Jr WG. (1999a). Oncogene, 18, 7701-7705.
19. Kaelin Jr WG. (1999b). J. Natl. Cancer Inst., 91, 594-598.
20. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F and Caput D. (1997). Cell, 90, 809-819.
21. Kelly JD, Inga A, Chen F-X, Dande P, Shah D, Monti P, Aprile A, Burns PA, Scott G, Abbondandolo A, Gold B and Fronza G (1999). J. Biol. Chem., 274, 18327-18334.
22. Ko LJ and Prives C. (1996). Genes Dev., 10, 1054-1072
23. Levine AJ. (1997). Cell, 88, 323-331.
24. Ludwig RL, Bates S and Vousden KH. (1996). Mol. Cell. Biol., 16, 4952-4960.
25. Marin MC, Jost CA, Brooks LA, Irwin MS, O'Nions J, Tidy JA, James N, McGregor JM, Harwood CA, Yulug IG, Vousden KH, Allday MJ, Gusterson B, Ikawa S, Hinds PW, Crook T and Kaelin Jr WG. (2000). Nat. Genet., 25, 47-54.
26. Melino G, De Laurenzi V and Vousden KH. (2002). Nat. Rev. Cancer, 2, 605-615.
27. Monti P, Campomenosi P, Ciribilli Y, Iannone R, Inga A, Abbondandolo A, Resnick MA and Fronza G. (2002) Oncogene, 21, 1641-1648
28. Monti P, Inga A, Aprile A, Campomenosi P, Menichini P, Ottaggio L, Viaggi S, Ghigliotti G, Abbondandolo A and Fronza G. (2000). Mutagenesis, 15, 127-132.
29. Nozaki M, Tada M, Kashiwazaki H, Hamou MF, Diserens AC, Shinohe Y, Sawamura Y, Iwasaki Y, de Tribolet N and Hegi ME. (2001). Brain Pathol., 11, 296-305.
30. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC and Hainaut P. (2002). Hum Mutat., 19, 607-614.
31. Prives C and Hall PA. (1999). J. Pathol., 187, 112-126.
32. Rowan S, Ludwig RL, Haupt Y, Bates S, Lu X, Oren M and Vousden KH. (1996). EMBO J., 15, 827-838.
33. Soussi T and May P. (1996). J. Mol. Biol., 260, 623-637.
34. Stiewe T and Pützer BM (2002). Cell Death Differ., 9, 237-245.
35. Tada M, Furuuchi K, Kaneda M, Matsumoto J, Takahashi M, Hirai A, Mitsumoto Y, Iggo RD and Moriuchi T. (2001). Carcinogenesis, 22, 515-517.
36. Vogelstein B, Lane D and Levine AJ. (2000). Nature, 408, 307-310.
37. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D and McKeon F. (1998). Mol. Cell, 2, 305-316.
38. Yuan ZM, Shioya H, Ishiko T, Sun X, Gu J, Huang YY, Lu H, Kharbanda S, Weichselbaum R and Kufe D. (1999). Nature, 399, 814-817.
39. Zaika AI, Slade N, Erster SH, Sansome C, Joseph TW, Pearl M, Chalas E and Moll UM. (2002). J. Exp. Med., 196, 765-780.